Literature DB >> 7945309

Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation.

Y Xie1, M C Hung.   

Abstract

The rat neu protooncogene encodes a 185 kD transmembrane protein (p185neu), which is a member of the epidermal growth factor receptor (EGFr) family. In searching for the signaling transducer of p185neu by using a two-hybrid selection system, we found, surprisingly, that the cytoplasmic domain of p185neu, when fused to the DNA-binding domain of GAL4 (amino acids 1-147), functioned as a transcriptional activator. We subsequently observed nuclear localization of p185neu. Interestingly, nuclear p185neu has a much higher extent of tyrosine phosphorylation than its nonnuclear counterpart. Our results suggest that a transmembrane receptor tyrosine kinase may enter the nucleus and be involved in transcriptional activation. This novel finding unveils a clue in the understanding of the mechanism of receptor tyrosine kinase-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945309     DOI: 10.1006/bbrc.1994.2368

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  48 in total

1.  Structure of Sad1-UNC84 homology (SUN) domain defines features of molecular bridge in nuclear envelope.

Authors:  Zhaocai Zhou; Xiulian Du; Zheng Cai; Xiaomin Song; Hongtao Zhang; Takako Mizuno; Emi Suzuki; Marla Rosanne Yee; Alan Berezov; Ramachandran Murali; Shiaw-Lin Wu; Barry L Karger; Mark I Greene; Qiang Wang
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

2.  Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor.

Authors:  Dipak K Giri; Mohamed Ali-Seyed; Long-Yuan Li; Dung-Fang Lee; Pin Ling; Geoffrey Bartholomeusz; Shao-Chun Wang; Mien-Chie Hung
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

3.  Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation.

Authors:  Judit Anido; Maurizio Scaltriti; Joan Josep Bech Serra; Belén Santiago Josefat; Federico Rojo Todo; José Baselga; Joaquín Arribas
Journal:  EMBO J       Date:  2006-06-22       Impact factor: 11.598

4.  EGFs and ERBBs--brief history and prospects.

Authors:  David F Stern
Journal:  Semin Cell Dev Biol       Date:  2010-10-21       Impact factor: 7.727

Review 5.  Nuclear trafficking of the epidermal growth factor receptor family membrane proteins.

Authors:  Y-N Wang; H Yamaguchi; J-M Hsu; M-C Hung
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

6.  Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors.

Authors:  Wenle Xia; Zuguo Liu; Rongrong Zong; Leihua Liu; Sumin Zhao; Sarah S Bacus; Yubin Mao; Jia He; Julia D Wulfkuhle; Emanuel F Petricoin; Takuya Osada; Xiao-Yi Yang; Zachary C Hartman; Timothy M Clay; Kimberly L Blackwell; Herbert K Lyerly; Neil L Spector
Journal:  Mol Cancer Ther       Date:  2011-06-14       Impact factor: 6.261

7.  Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells.

Authors:  Lakshmi Reddy Bollu; Jiangong Ren; Alicia Marie Blessing; Rajasekhara Reddy Katreddy; Guang Gao; Lei Xu; Jinrong Wang; Fei Su; Zhang Weihua
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 8.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.

Authors:  M M Moasser
Journal:  Oncogene       Date:  2007-04-30       Impact factor: 9.867

9.  Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.

Authors:  Mattias K Andersson; Melker Göransson; Anita Olofsson; Carola Andersson; Pierre Aman
Journal:  BMC Cancer       Date:  2010-06-01       Impact factor: 4.430

10.  Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect.

Authors:  Kohji Yamada; Mutsumi Hayashi; Wenlin Du; Kei Ohnuma; Michiie Sakamoto; Chikao Morimoto; Taketo Yamada
Journal:  Cancer Cell Int       Date:  2009-06-26       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.